Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-28

FDA Approved: EPINEPHRINE — Supplemental Application (American Regent, Inc.)

View source ↗

Summary

FDA approved a supplemental application for EPINEPHRINE from American Regent, Inc., indicating an approved change to the product's labeling or formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPINEPHRINE (EPINEPHRINE)

Snippet

SUPPL AP for EPINEPHRINE (EPINEPHRINE)